+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Middle East & Africa Asparaginase Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and End-use Industry

  • PDF Icon

    Report

  • 100 Pages
  • November 2022
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5701697
UP TO OFF until Dec 31st 2024
The MEA asparaginase market is expected to grow from US$ 22.60 million in 2022 to US$ 48.37 million by 2028; it is estimated to grow at a CAGR of 13.5% from 2022 to 2028.

The pharmaceutical & food industries are constantly developing at a significant rate due to the rising demand from a large population. The industries have increased new product development, product launches, and approvals across the MEA. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. In recent years, the market is experiencing various developments, such as product launches and approvals, which are likely to create ample opportunities in the market. For instance, In July 2021, Ligand Pharmaceuticals Incorporated partnered with Jazz Pharmaceuticals Plc to launch Rylaze [asparaginase E. chrysanthemi (recombinant)-rywn], also known as JZP458. Rylaze is a recombinant Erwinia asparaginase used as a component of a multi-agent chemotherapeutic regimen for treating acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) in adult and pediatric patients (1 month or older) who have developed hypersensitivity to E. coli-derived asparaginase. Similarly, in August 2020, Lonza expanded microbial capacity and extended a long-term partnership with Servier Pharmaceuticals, Inc. for l-asparaginase API manufacturing. The new facility will provide mid-scale commercial manufacturing to multiple customers and serve the growing needs of Servier, an independent international pharmaceutical company and long-term Lonza partner. Thus, the increase in new product development, launches, and other strategic collaborations among market players are likely to create ample opportunities for the asparaginase market growth in the coming years.

Market Overview

The MEA asparaginase market is segmented into the UAE, Saudi Arabia, South Africa, and Rest of MEA. Saudi Arabia dominated the market in 2022. Saudi Arabia is one of the important countries in the MEA that has significant scope for the cancer treatment market. The healthcare system in the country is developing at a rapid pace and an increasing number of international companies are developing medical and research teams in the country. Also, a sharp increase in the state health budget is expected to drive the demand for cancer drugs in the country. Saudi Arabia has a huge population base who suffer from cancer. As per the data of WHO, in 2020, approximately 27,885 new cases of cancer were registered in the country, including ~1,698 non-Hodgkin lymphoma (NHL) cases and 1,676 cases of leukemia. Moreover, a study published by King Abdul-Aziz City for Science and Technology (KACST) demonstrated that the marine environment of the Red Sea has the potential to be a potent source of bacterial strains for the discovery of anticancer drugs. The identification of strains with improved ASNase yields has attracted significant attention to improve the cost-effectiveness of these enzymes. Thus, above-mentioned factors are expected to drive the growth of asparaginase market in the coming years in the country.

MEA Asparaginase Market Segmentation

The MEA asparaginase market is segmented based on type, application, end-use industry, and country.
  • Based on type, the MEA asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022.
  • Based on application, the MEA asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others.
  • Based on end-use industry, the MEA asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held the larger market share in 2022.
  • Based on country, the MEA asparaginase market has been categorized into the UAE, Saudi Arabia, South Africa, and rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022. Biovendor, LLC; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the MEA asparaginase market.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Asparaginase Market - By Type
1.3.2 MEA Asparaginase Market - By Application
1.3.3 MEA Asparaginase Market - By End-Use Industry
1.3.4 MEA Asparaginase Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Asparaginase Market - Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Asparaginase Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Leukemia and Increasing Usage Application
5.1.2 Significant Growth of Pharmaceutical and Food Industry
5.2 Market Restraints
5.2.1 Side Effects Associated With Use of Asparaginase
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.4 Future Trends
5.4.1 Increase in R&D Activities and Investment by Market Players
5.5 Impact Analysis
6. Asparaginase Market- MEA Analysis
6.1 MEA Asparaginase Market Revenue Forecasts and Analysis
7. MEA Asparaginase Market Analysis - By Type
7.1 Overview
7.2 By Type: MEA Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Escherichia Coli
7.2.1.1 Overview
7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Erwinia Chrysanthemi
7.2.2.1 Overview
7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
7.2.3 Pegylated
7.2.3.1 Overview
7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)
7.2.4 Others
7.2.4.1 Overview
7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. MEA Asparaginase Market Analysis - By Application
8.1 Overview
8.2 By Application: MEA Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Therapeutic
8.2.1.1 Overview
8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)
8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 Lymphoblastic Lymphoma (LBL)
8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.5 Others
8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Food Processing
8.2.2.1 Overview
8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)
8.2.3 Others
8.2.3.1 Overview
8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Asparaginase Market Analysis - By End-use Industry
9.1 By End-Use: MEA Market Revenue and Forecast Analysis (US$ Million)
9.1.1 Healthcare
9.1.1.1 Overview
9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)
9.1.2 Food Manufacturing
9.1.2.1 Overview
9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Asparaginase Market - Country Analysis
10.1 Overview
10.1.1 MEA Asparaginase Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.3 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.1.4 Saudi Arabia: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)
10.1.1.1.5 Saudi Arabia: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)
10.1.1.2 South Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.3 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.2.4 South Africa: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.2.4.1 South Africa: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)
10.1.1.2.5 South Africa: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)
10.1.1.3 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.3 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.3.4 UAE: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.3.4.1 UAE: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)
10.1.1.3.5 UAE: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)
10.1.1.4 Rest of Middle East and Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.3 Rest of MEA: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.4.4 Rest of MEA: Asparaginase Market, By Application, 2020 - 2028 (US$ Million)
10.1.1.4.4.1 Rest of MEA: Asparaginase Market, By Therapeutic Application, 2020 - 2028 (US$ Million)
10.1.1.4.5 Rest of MEA: Asparaginase Market, by End-Use, 2020 - 2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Servier Pharmaceuticals LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Biovendor, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Enzymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Taj Pharmaceuticals Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 medac GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Jazz Pharmaceuticals, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 United Biotech (P) Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. MEA Asparaginase Market- Revenue and Forecast to 2028 (US$ Mn)
Table 2. Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)
Table 3. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 4. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)
Table 5. Saudi Arabia: Asparaginase Market, by End-Use - Revenue and Forecast to 2028 (US$ Million)
Table 6. South Africa Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)
Table 7. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 8. South Africa: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)
Table 9. South Africa: Asparaginase Market, by End-Use - Revenue and Forecast to 2028 (US$ Million)
Table 10. UAE: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)
Table 11. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 12. UAE: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)
Table 13. UAE: Asparaginase Market, by End-Use - Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of MEA: Asparaginase Revenue and Forecasts To 2028, By Type (US$ Million)
Table 15. Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 16. Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Million)
Table 17. Rest of MEA: Asparaginase Market, by End-Use - Revenue and Forecast to 2028 (US$ Million)
Table 18. Recent Inorganic Growth Strategies
Table 19. Recent Organic Growth Strategies
Table 20. Glossary of Terms
List of Figures
Figure 1. MEA Asparaginase Market Segmentation
Figure 2. MEA Asparaginase Market Segmentation, by Country
Figure 3. MEA Asparaginase Market Overview
Figure 4. MEA Asparaginase Market, By Type
Figure 5. MEA Asparaginase Market, By Country
Figure 7. MEA: PEST Analysis
Figure 8. Experts Opinion
Figure 9. MEA Asparaginase Market Impact Analysis of Drivers and Restraints
Figure 1. MEA Asparaginase Market - Revenue Forecasts and Analysis
Figure 1. By Type: MEA Market Analysis and Forecast 2021 and 2028 (%)
Figure 1. MEA Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. MEA Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. MEA Pegylated Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. MEA Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. By Application: MEA Market Analysis and Forecast 2021 and 2028 (%)
Figure 1. MEA Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. MEA Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)
Figure 1. MEA Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. MEA Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Food Processing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. By End-Use: MEA Market Analysis and Forecast 2021 and 2028 (%)
Figure 24. MEA Healthcare Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Asparaginase Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 27. MEA Asparaginase Market Revenue and Forecasts to 2028, By Country (%)
Figure 28. Saudi Arabia: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. South Africa: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. UAE: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Rest of MEA: Asparaginase Market Revenue and Forecasts to 2028 (US$ Million)

Companies Mentioned

  • Biovendor, Llc
  • Creative Enzymes
  • Jazz Pharmaceuticals, Inc.
  • Medac Gmbh
  • Servier Pharmaceuticals Llc
  • Taj Pharmaceuticals Limited
  • United Biotech (P) Limited

Table Information